Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: Insights from renal ultrastructural findings
- 4 April 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Autoimmunity
- Vol. 111, 102443
- https://doi.org/10.1016/j.jaut.2020.102443
Abstract
No abstract availableFunding Information
- Cluster Alisei (MEDINTECH CTN01_00177_962,865)
- European Research Council (ERC – N° 669,415)
- Padova University (DORI_SID19_01)
This publication has 28 references indexed in Scilit:
- Changing patterns in clinical–histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritisAnnals Of The Rheumatic Diseases, 2018
- Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort studyRenal Failure, 2017
- Update on Lupus NephritisClinical Journal of the American Society of Nephrology, 2016
- Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 miceJournal of Autoimmunity, 2016
- Risk of End‐Stage Renal Disease in Patients With Lupus Nephritis, 1971–2015: A Systematic Review and Bayesian Meta‐AnalysisArthritis & Rheumatology, 2016
- PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus GlomerulonephritisClinical Reviews in Allergy & Immunology, 2015
- Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus NephritisThe New England Journal of Medicine, 2011
- IgG anti-pentraxin 3 antibodies in systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2010
- Long-Term Prognosis and Causes of Death in Systemic Lupus ErythematosusThe American Journal of Medicine, 2006
- PENTRAXINS AT THE CROSSROADS BETWEEN INNATE IMMUNITY, INFLAMMATION, MATRIX DEPOSITION, AND FEMALE FERTILITYAnnual Review of Immunology, 2005